Lääkealan turvallisuus- ja kehittämiskeskus Fimea - Selaus nimekkeen mukaan
Viitteet 16-35 / 5155
-
A case of adverse drug reaction : drug fever caused by hydroxycarbamide
(Lääkelaitos, 2003) -
A case of adverse drug reaction : drug fever caused by hydroxycarbamide
Tabu : 6 (Lääkelaitos, 2003) -
A Comparative Review of Marketing Authorization Decisions in Switzerland, the EU, and the USA
Therapeutic Innovation and Regulatory Science (SAGE Publications Inc., 19.04.2018) -
A drug or a foodstuff?
(Lääkelaitos, 2003) -
A drug or a foodstuff?
Tabu : 6 (Lääkelaitos, 2003) -
A history of diabetes but not hyperglycaemia during exacerbation of obstructive lung disease has impact on long-term mortality: a prospective, observational cohort study
BMJ Open (BMJ Publishing Group, 29.01.2015) -
A joint effort in medicines education
(Lääkelaitos, 2007) -
A joint effort in medicines education
Tabu : 1 (Lääkelaitos, 2007) -
A national approach to medicines information research : A systematic review
Research in Social and Administrative Pharmacy (Elsevier Inc, 2018)Background: The Finnish Medicines Agency Fimea published the first national medicines information (MI) strategy in 2012. For the purpose of implementing the MI strategy into practice by the national MI Network, a ... -
A new Finnish Medicines Agency - what is happening?
(Lääkelaitos, 2009) -
A new Finnish Medicines Agency - what is happening?
Tabu : 3/4 (Lääkelaitos, 2009) -
A regulatory perspective on the availability of medicines and medicine shortages in outpatient care : case Finland
International Journal of Clinical Pharmacy : 4 (07 / 2019) -
A remedy for the problem of medicines' availability
(Lääkelaitos, 2004) -
A remedy for the problem of medicines' availability
Tabu : 5 (Lääkelaitos, 2004) -
A renewed TABU
(Lääkelaitos, 1999) -
A systematic review of the impact of potentially inappropriate medication on health care utilization and costs among older adults
Medical Care : 10 (Lippincott Williams and Wilkins, 2016) -
A year of pharmaceutical marketing - 2006
(Lääkelaitos, 2007) -
A year of pharmaceutical marketing - 2006
Tabu : 2 (Lääkelaitos, 2007) -
A-, D- ja E-vitamiineja sisältävien injektionesteiden teurasvaroajat pidennetty 28 vuorokauteen
Tabu : 2 (Lääkelaitos, 2006)